MedPath

effect of vitamin D on decreasing blood pressure

Phase 3
Completed
Conditions
hypertension and vitamin D deficiency.
Secondary hypertension
Registration Number
IRCT20190105042238N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

serum level vitamin D between 10-30 ng/dl
having hypertension stage 1

Exclusion Criteria

CKD> 1.2 mg / dL
Liver failure patients
Proteinuria greater than 500 mg in 24 hours
Patients with heart failure
Pregnancy
Secondary hypertension
No consumption more than 20% of the drug delivered to them

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypertension. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: 24-hour blood pressure monitoring and measurement.
Secondary Outcome Measures
NameTimeMethod
Measurement of vitamin d. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Through a laboratory test.
© Copyright 2025. All Rights Reserved by MedPath